| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $18.2M | -21.5% |
| R&D Expense | $3.8M | -13.4% |
| SG&A Expense | $28.9M | -33.3% |
| Operating Income | -$32.0M | +42.6% |
| Pre-tax Income | -$24.9M | +56.8% |
| Income Tax | $0 | -100.0% |
| Net Income | -$36.6M | +36.5% |
| EPS (Basic) | -$0.81 | +55.0% |
| EPS (Diluted) | -$0.81 | +55.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.6M | -59.7% |
| Accounts Receivable | $1.6M | +264.2% |
| Current Assets | $31.8M | -32.2% |
| Total Assets | $59.7M | -20.3% |
| Current Liabilities | $15.7M | +81.7% |
| Total Liabilities | $46.2M | -3.8% |
| Stockholders' Equity | $13.4M | -50.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$19.9M | +41.6% |
| Investing Cash Flow | -$10.5M | -247.3% |
| Financing Cash Flow | $10.0M | -82.6% |